By Alex Lawson ( April 21, 2014, 3:52 PM EDT) -- Pronova BioPharma Norge AS has asked the U.S. Supreme Court to shed light on a statutory provision that renders patents invalid if they cover technology that has been in "public use" for over a year, arguing that the Federal Circuit bungled the rule in nixing its patent for triglyceride-lowering drug Lovaza....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.